Sarepta Therapeutics, Inc 10-Q for FY2023 Q3
Sarepta Therapeutics, Inc. (SRPT)
10-Q
2023-11-01
For: 2023-09-30
View Original
Added on
April 11, 2026
About this 10-Q
Sarepta Therapeutics, Inc filed this 10-Q on November 1, 2023, covering the quarter ended September 30, 2023 (FY2023 Q3).
Headline figures
Quarter ended September 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $331.82M
- up 44.1% from $230.27M a year earlier
- Net loss
- $40.94M
- compared with a net loss of $257.74M a year earlier
- Diluted EPS
- -$0.46
- compared with -$2.94 a year earlier